Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Squamous Intraepithelial Lesions 2Dyspareunia 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1Ovarian Neoplasms 1HIV Infections 1Endometrial Neoplasms 1Breast Neoplasms 1Bowen's Disease 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 33Paclitaxel 27Cyclophosphamide 25Carboplatin 23olaparib 21Fulvestrant 15fludarabine 14Trastuzumab 14aldesleukin 13Docetaxel 13Early Intervention, Educational 12Surveys and Questionnaires 11veliparib 10palbociclib 10Methods 10Gemcitabine 10Blood Specimen Collection 10Nivolumab 9Flow Cytometry 9Biopsy 9Bevacizumab 9sargramostim 8niraparib 7liposomal doxorubicin 7Therapeutics 7Taxes 7Standard of Care 7Psychiatric Rehabilitation 7Magnetic Resonance Spectroscopy 7talazoparib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Laser Therapy × Gynecologic × Clear all
NCT03307044 2023-03-20

Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Ohio State University Comprehensive Cancer Center

Phase NA Completed
66 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Dyspareunia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡